文献速递前列腺癌

DaVinci与Hugo™ RAS机器人平台用于机器人辅助根治性前列腺切除术的头对头比较:比较性研究的系统评价与Meta分析

Head-to-head comparison of DaVinci and Hugo™ RAS robotic platforms for robot-assisted radical prostatectomy: a systematic review and meta-analysis of comparative studies.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-10-15

该研究系统检索并Meta分析了8项比较性研究(3项前瞻性、5项回顾性),共1114例接受机器人辅助根治性前列腺切除术的患者(Hugo™RAS组454例,DaVinci组660例)。结果显示两组在总手术时间、控制台时间、出血量、神经保留、淋巴结清扫、并发症、住院时间、导管留置时间、切缘阳性、分期及尿控恢复上无显著差异,但Hugo™RAS对接时间显著更长(MD 6分钟,95%CI 4.2;7.8),淋巴结产出显著更低(MD -2,95%CI -3.3;-0.6)。

要点

  • Hugo™RAS对接时间较DaVinci显著延长,平均差6分钟(95%CI 4.2;7.8)。
  • Hugo™RAS淋巴结产出较DaVinci显著降低,平均差-2枚(95%CI -3.3;-0.6)。
  • 其余手术、病理及功能结局在两种平台间无显著差异。

核心结论

  • Meta分析提示Hugo™RARP与DV-RARP在大多数分析结局上无统计学差异,除外对接时间和淋巴结产出。
  • Hugo™RAS对接时间更长提示设置要求高,但未转化为总手术时间显著延长。
  • 淋巴结产出的差异虽有统计学意义,但临床可能可忽略。

研究设计与样本

  • 系统评价与Meta分析,遵循PRISMA指南并在PROSPERO注册(CRD42024562326)。
  • 2024年6月检索学术数据库,聚焦2021至2024年文章。
  • 纳入8项比较性研究(3项前瞻性、5项回顾性),共1114例患者(H-RARP 454例 vs DV-RARP 660例)。
  • 连续变量用均数差(MD)汇总,分类变量用比值比(OR)及95%CI汇总。
  • 异质性用Cochran Q检验和I²统计量评估,发表偏倚用Egger和Begg检验评估,显著性设定为p<0.05。

主要发现

  • 总手术时间、控制台时间、出血量、神经保留及淋巴结清扫在两组间无显著差异。
  • Hugo™RAS对接时间显著长于DaVinci(MD 6分钟,95%CI 4.2;7.8)。
  • 并发症、住院时间及导管留置时间在两组间相似。
  • 切缘阳性或分期在两组间无显著差异,但H-RARP淋巴结产出更低(MD -2,95%CI -3.3;-0.6)。
  • 尿控恢复在两组间相当。

关键数值与推荐

  • 对接时间:Hugo™RAS较DaVinci平均差6分钟(95%CI 4.2;7.8)。
  • 淋巴结产出:H-RARP较DV-RARP平均差-2枚(95%CI -3.3;-0.6)。
  • 偏倚风险为中至严重。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 偏倚风险为中至严重。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We conducted a systematic review and meta-analysis of comparative studies to analyze intra- and postoperative outcomes of robot-assisted radical prostatectomy (RARP) using either DaVinci (DV-RARP) or Hugo™RAS (H-RARP) platforms. METHODS: The study was registered in PROSPERO (CRD42024562326) and followed PRISMA guidelines. Literature search was conducted in June 2024 using academic databases, focusing on articles from 2021 to 2024. Research question focused on men with PCa (P) undergoing H-RARP (I) versus DV-RARP (C) to evaluate surgical, pathology, and functional outcomes (O), across comparative studies. Continuous variables were summarized using mean difference (MD) and categorical variables using odds ratio with 95% confidence intervals (CI). Heterogeneity was assessed using Cochran's Q test and I2 statistics. Publication bias was evaluated with Egger's and Begg's tests. Statistical analysis was performed with Stata®17.0, with significance set at p < 0.05. Risk of bias was assessed using the ROBINS-I tool. Methodological quality was evaluated with AMSTAR 2. RESULTS: Eight studies (three prospective, five retrospective) with 1114 patients (454 H-RARP vs. 660 DV-RARP) were included. Baseline characteristics were comparable between groups. No significant differences were found in overall operative time, console time, blood loss, nerve-sparing, or lymphadenectomy. Docking time was significantly longer for Hugo™RAS (MD:6 min,95% CI 4.2;7.8). Postoperative outcomes, including complications, length of stay, and catheterization time, were similar. Pathological outcomes showed no significant differences in positive surgical margins or staging, but lower node yield was observed with H-RARP (MD:-2,95% CI -3.3;-0.6). Urinary continence recovery was comparable. Risk of bias was moderate to serious. CONCLUSION: The meta-analysis suggests H-RARP and DV-RARP perform not statistically different across most of analyzed outcomes, except for docking time and lymph-node yield. The longer docking time associated with the Hugo™RAS suggests demanding setup but does not translate into significantly longer operative time. Although statistically significant, the observed difference in lymph-node yield might be clinically negligible.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Ditonno F, Pettenuzzo G, Montanaro F, et al. Head-to-head comparison of DaVinci and Hugo™ RAS robotic platforms for robot-assisted radical prostatectomy: a systematic review and meta-analysis of comparative studies. Prostate Cancer Prostatic Dis. 2024. PMID: 39402370. doi:10.1038/s41391-024-00908-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。